logo

For the Inventor, By the Inventor

Barcelona, Spain

Jordi Frigola-Constansa

USPTO Granted Patents = 40 

 

 

Average Co-Inventor Count = 2.7

ph-index = 8

Forward Citations = 226(Granted Patents)


Location History:

  • Av. Diagonal, ES (1995)
  • Barcelone, ES (2001 - 2002)
  • Baracelona, ES (2006)
  • Sant Just Desvern, ES (2011)
  • Barcelona, ES (1992 - 2012)

Company Filing History:

goldMedal32 out of 150 
 
Laboratorios Del Dr. Esteve S.a.
 patents
silverMedal7 out of 23 
 
Laboratories Del Dr. Esteve S.a.
 patents
bronzeMedal1 out of 1 
 
Laboratories Del Sr. Esteve, S.a.
 patent

Years Active: 1992-2012

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Indene Derivatives
Sulfonamide Compounds
Pyrazoline Compounds
Tetrahydropyridine Derivatives
Aryl Piperazinylalkylazole
Benzimidazole Derivatives
Pharmaceutical Compositions
Medicinal Chemistry
Triglyceride Reduction
Pain Management
Antihistaminics
Enantiomer Resolution
40 patents (USPTO):Explore Patents
1. 8217041 - Indene derivatives, their preparation and use as medicaments (2012-07-10),
2. 8138210 - Substituted indanyl sulfonamide compounds, their preparation and use as medicaments (2012-03-20),
3. 7998996 - Substituted pyrazoline compounds for reducing triglycerides in blood (2011-08-16),
4. 7498328 - Derivatives of sulphonamides, their preparation and use as medicaments (2009-03-03),
5. 7452881 - Derivatives of sulphonamides, their preparation and use as medicaments (2008-11-18),
6. 7300937 - Derivatives of cyano-aryl (or cyanoheteroaryl)-carbonyl-piperazinyl-pyrimidines, their preparation and application as medication (2007-11-27),
7. 7176200 - Derivatives of sulphonamides, their preparation and use as medicaments (2007-02-13),
8. 7129361 - Thienylazolylalkoxyethanamines, their preparation and their application as medicaments (2006-10-31),
9. 7105515 - Derivatives of sulphonamides, their preparation and use as medicaments (2006-09-12),
10. RE39113 - Utilization of derivatives of tetrahydropyridines(or 4-hydroxypiperidines)-butylazols in the preparation of a medicament for the treatment of pain (2006-05-29),
11. 7041665 - Benzoxazinone derivatives, their preparation and use as medicaments (2006-05-09),
12. RE38963 - Pyrazoline derivatives, their preparation and application as medicaments (2006-01-30),
13. 6958403 - [object Object] (2005-10-25),
14. 6846935 - Procedure for the preparation of racemic and enantionmerically pure derivatives of 1,5-diaryl-3-trifluoromethyl-Δ2-pyrazolines (2005-01-25),
15. 6518295 - Utilization of aryl(or heteroaryl)azolylcarbinol derivatives in the preparation of a medicament for the treatment of troubles mediated by an excess of substance P (2003-02-11),

Title: The Pioneering Work of Jordi Frigola-Constansa in Innovation and Sustainability

Introduction:

Jordi Frigola-Constansa, a visionary inventor based in Barcelona, Spain, has been at the forefront of groundbreaking inventions that not only showcase his dedication to innovation but also highlight his commitment to sustainability. With a portfolio of 40 patents under his belt, his contributions have left a lasting impact on the field and continue to inspire future generations of inventors.

Latest Patents:

Among his latest patents is the development of Indene derivatives, which are new compounds effective for treating diseases mediated by certain receptors. Additionally, Frigola-Constansa has made significant strides in the creation of substituted indanyl sulfonamide compounds, further expanding the possibilities for pharmaceutical applications.

Career Highlights:

Frigola-Constansa is affiliated with Laboratorios Del Dr. Esteve S.A., a prominent pharmaceutical company known for its innovative research and development initiatives. His collaboration with esteemed colleagues such as Ramon Merce-Vidal and Juan Pares-Corominas has led to the successful implementation of cutting-edge technologies and novel approaches in the field of medicine.

Collaborations:

Working alongside like-minded individuals, Frigola-Constansa has been able to leverage his expertise and creativity to drive forward-thinking solutions in the realm of healthcare. Through collaborative efforts, he has been able to navigate complex challenges, overcome barriers, and pave the way for transformative inventions that have the potential to revolutionize the industry.

Conclusion:

Jordi Frigola-Constansa's remarkable journey as an inventor epitomizes the fusion of innovation and sustainability, setting a remarkable standard for future inventors to follow. His relentless pursuit of excellence, coupled with his passion for creating impactful solutions, underscores his invaluable contributions to the field of inventions. As he continues to push the boundaries of what is possible, Frigola-Constansa remains a beacon of inspiration for those looking to make a lasting difference through their innovative endeavors.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…